ArticleInvestigational new drugs2017

A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors.

Gun Min Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.